HC ANDERSEN CAPITAL

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst

Name: Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst
Start: 2023-08-25T13:00:00+0200
End: 2023-08-25T13:30:00+0200

AUTHOR

Mie

DATE

15. August 2023

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst 25 AugustAug 2023 13:00 - 13:30Online Event

Tilmeld

Information

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst 25 AugustAug 2023 13:00 - 13:30

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst Online Event

Tilmeld

OrderYOYO – Presentation of half-year report H1 2023

Hafnia – Presentation of Half-year report 2023

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Advisor on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst

Bavarian Nordic – Q2, rejsevacciner viser forsat stærk vækst

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital